Introduction
============

Over the last few decades, a lot of research concerning electroencephalogram (EEG) alpha asymmetry (AA) in depressive disorders (DD) has been conducted. EEG is of interest in respect of diagnosis of DD, with a special focus on frontal EEG AA,[@b1-ndt-14-1493],[@b2-ndt-14-1493] as it is believed to be a useful biomarker for depression.[@b1-ndt-14-1493]--[@b3-ndt-14-1493] EEG AA is usually calculated by subtracting the right-side EEG power estimates from the respective counterpart on the other side. While normal controls have more right-sided frontal alpha power, depressive patients seem to have comparatively higher left frontal alpha power.[@b1-ndt-14-1493],[@b2-ndt-14-1493],[@b4-ndt-14-1493] Cortical activity is related to reduced EEG power, which is reflected in left frontal hypoactivation in depressed subjects and as a deficit in approach mechanisms.[@b5-ndt-14-1493] On the other hand, higher alpha power could be interpreted as correlate of active inhibition rather than cognitive idleness.[@b6-ndt-14-1493]--[@b8-ndt-14-1493] Several meta-analyses attempted to shed light on the usefulness of EEG AA for diagnostic purposes.[@b9-ndt-14-1493],[@b10-ndt-14-1493] While Gold et al[@b8-ndt-14-1493] concluded that there is sufficient reliability of frontal AA, correlations with depression scales were small and nonsignificant. The most recent meta-analysis including 883 major depressed patients and 2,161 controls found only a nonsignificant effect size for EEG AA in respect of major DD.[@b10-ndt-14-1493] Gender, age, and severity of depression were especially identified as covariates of EEG AA.[@b10-ndt-14-1493]

While many studies focus on depressive symptoms, there are, however, several subtypes of DD in terms of symptoms, duration, and etiology. In clinical routine, DD are diagnosed by a physician using ICD-10,[@b11-ndt-14-1493] *Diagnostic and Statistical Manual of Mental Disorders*, Fourth Edition (DSM-IV),[@b12-ndt-14-1493] or *Diagnostic and Statistical Manual of Mental Disorders*, Fifth Edition (DSM-V)[@b13-ndt-14-1493] criteria. Depression scales are common for further specification of symptomatology and as diagnostic tools.

Another issue worth considering is the fact that most studies include only young patients,[@b14-ndt-14-1493] and studies including older individuals were not able to replicate the diagnostic validity of EEG AA.[@b15-ndt-14-1493]--[@b17-ndt-14-1493] One major problem in this context might be publication bias, which makes it hard to publish negative results on EEG AA and leads to overinterpretation of results. Another interesting aspect is the fact that most studies deal with female individuals and not with males. Since frontal AA was found to be more consistent in women,[@b18-ndt-14-1493] many studies focus only on females.

While age and gender data are easily obtained, handedness needs specific testing. Simple verbal information about the presumed handedness does not give valid information about hemispheric lateralization. The Edinburgh Handedness Inventory[@b19-ndt-14-1493] can be used for proper documentation. Jesulola et al[@b20-ndt-14-1493] did not report handedness and argued that hemispheric brain dominance is not only determined by handedness. Approximately 61%--70% of left-handed people have left hemispheric dominance.[@b21-ndt-14-1493],[@b22-ndt-14-1493] As mentioned before, age seems to be a covariate of EEG AA, which raises the question if cognition is also a covariate. Cognition of participants is mostly ignored, although evidence for alpha 1 power correlation with cognitive abilities was found.[@b23-ndt-14-1493] Alpha power and theta power are correlated with memory decline[@b24-ndt-14-1493],[@b25-ndt-14-1493] and cognitive decline.[@b26-ndt-14-1493] Aging must be considered in respect of EEG AA, as there are specific age-related changes that could explain why EEG AA changes are not found in geriatric patients.[@b16-ndt-14-1493] One important theory, the right hemi-aging hypothesis, proposes that the right hemisphere is more affected by age-related changes.[@b27-ndt-14-1493] This kind of hemispheric difference could also affect AA. Cabeza[@b28-ndt-14-1493] established the "hemispheric asymmetry reduction in old adults" model, which assumes that hemispheric asymmetry is reduced during cognitive performance and reflects compensatory mechanisms. A third theory named "compensation-related utilisation of neural circuits hypothesis" states that elderly individuals activate additional brain regions not only from the contralateral hemisphere.[@b29-ndt-14-1493] Closely related to cognitive ability is education, which could be easily ascertained and might as well affect EEG measures. Furthermore, educational biases between groups need to be ruled out in addition to gender, age, and cognition. Even sexual motivation seems to affect frontal AA,[@b30-ndt-14-1493] expressed in a positive relationship between self-reported mental sexual arousal and a more left-sided AA. While most studies report findings on EEG AA, it is hard to find a consensus on what the alpha band range is. Some studies use fixed ranges, while others use individual alpha bands.[@b31-ndt-14-1493] Evidence for age-related individual alpha frequency changes can be found, and also for smaller amplitudes in older adults.[@b32-ndt-14-1493] Controlling for drugs is another important possible confounder in studies on EEG AA. While many studies[@b15-ndt-14-1493],[@b16-ndt-14-1493],[@b85-ndt-14-1493] describe medication taken by the probands, any effects on the recorded EEG are simply ignored.

Summarizing the findings on EEG AA, it becomes evident that diagnostic validity is limited. One reason for this limitation could be the poor quality of some studies on EEG AA; also sample selection seems to affect the outcome. The aim of this review was to sum up methods used in studies on EEG AA and discuss potential flaws, which devalue the outcome and cannot help to shed light on the diagnostic validity of EEG AA. Not only handedness, gender, age, and education ought to be addressed but also culture, medication, and cognition need to be considered. A list of minimal requirements needs to be created in order to improve the quality of future studies on EEG AA and make the results comparable.

Materials and methods
=====================

Search procedure and characteristics of identified studies
----------------------------------------------------------

On 13 July 2017, a search of PubMed was conducted using the combination of the following keywords in title and abstract: alpha asymmetry, depression, and EEG. Overall, the search resulted in finding 61 articles. Only studies that determined asymmetry on the basis of EEG data were included. Inclusion criteria for this review were a focus on EEG AA and affective disorders. Studies whose research focus was on the analysis of other EEG correlates instead of AA and/or other mental disorders or main symptoms that did not include depression symptoms were excluded. No study was excluded due to methodological limitations, but rather because it missed the proposed research topic. In the next step, cultural background, type of study, sample size, percentage of right-handers, and number of female participants were collected. Furthermore, we collected data on education, reference style, recording protocol and length, as well as impedance and alpha band range. Moreover, "controlling for handedness" and "controlling for drugs" were added. All collected data were transferred to Microsoft Excel 2016. Descriptive data analysis was performed using IBM SPSS Statistics 24.

Results
=======

A total number of 61 publications were found using the following search criteria in PubMed (<https://www.ncbi.nlm.nih.gov/pubmed/>): (alpha asymmetry\[Title/Abstract\]) AND (depression\[Title/Abstract\]) AND (eeg\[Title/Abstract\]).

In all, 17 studies were excluded from further analysis since they did not fully meet search criteria.[@b33-ndt-14-1493]--[@b49-ndt-14-1493] From the remaining 44 studies published between 1996 and 2017, we collected data on the methods used.

Topical heterogeneity of included literature
--------------------------------------------

While all studies included in this study addressed EEG AA in DD, most of the studies tried to test the validity of EEG AA as a surrogate marker for depression and claimed to show evidence for that.[@b4-ndt-14-1493],[@b50-ndt-14-1493]--[@b56-ndt-14-1493] Some of the studies addressed specific topics such as melancholia and EEG AA.[@b57-ndt-14-1493] It is inferred that it remains unclear whether this can be used as a surrogate marker or not.[@b8-ndt-14-1493],[@b10-ndt-14-1493],[@b20-ndt-14-1493],[@b58-ndt-14-1493] Anxiety was found to be correlated with the most evident relative change in frontal alpha asymmetry in one study.[@b54-ndt-14-1493] Some studies only proved EEG AA findings for anxiety and not for depression.[@b59-ndt-14-1493] EEG AA changes were found only in schizophrenia and depression and not in other clinical disorders.[@b60-ndt-14-1493] In addition, a general decrease in EEG power in all frequency bands in depression[@b61-ndt-14-1493] as well as a lowered frontal EEG power in rumination was found.[@b62-ndt-14-1493] Shyness was also a criterion and was able to predict greater relative right frontal AA only after controlling for depressive mood[@b63-ndt-14-1493] and self-esteem, which was found to be a mediator of EEG AA only in its explicit type.[@b64-ndt-14-1493] In suicide attempters, greater alpha power over the left hemisphere was found.[@b65-ndt-14-1493] One study addressed activity level in general, which might be correlated to EEG AA.[@b66-ndt-14-1493] Some interventional studies also proved a shift in EEG AA.[@b35-ndt-14-1493],[@b67-ndt-14-1493]--[@b69-ndt-14-1493] A prediction of the course of depression was not possible with EEG AA.[@b70-ndt-14-1493] There was also a focus on whether EEG AA is a state or trait marker for depression,[@b16-ndt-14-1493],[@b71-ndt-14-1493],[@b72-ndt-14-1493] which still remains undetermined.[@b72-ndt-14-1493] A large number of the studies were not able to prove the diagnostic reliability of EEG AA.[@b73-ndt-14-1493]--[@b75-ndt-14-1493] In particular, findings on correlations between depression scores and EEG AA were inconsistent.[@b8-ndt-14-1493],[@b79-ndt-14-1493] Studies that addressed age had difficulties in validating previous findings on EEG AA.[@b16-ndt-14-1493],[@b17-ndt-14-1493],[@b80-ndt-14-1493] Especially in young people and the oldest olds, previous EEG AA findings were not able to be replicated.[@b16-ndt-14-1493],[@b17-ndt-14-1493] Other factors such as cortical thickness as a mediator of AA could be ruled out.[@b81-ndt-14-1493] Cognition was discussed as a possible moderator of EEG AA.[@b15-ndt-14-1493]--[@b17-ndt-14-1493],[@b82-ndt-14-1493],[@b83-ndt-14-1493] Hereditary effects might play a role,[@b84-ndt-14-1493] but it was found that less left frontal activity at lateral sites was only associated with lifetime major depressive disorder (MDD) in offspring and not in parental MDD.[@b47-ndt-14-1493] The issue of drug effects on EEG AA was discussed.[@b85-ndt-14-1493] It was also argued that conventional EEG analysis lacks temporal and spatial precision.[@b56-ndt-14-1493]

Methodological analysis
-----------------------

In [Table 1](#t1-ndt-14-1493){ref-type="table"}, a comparison of methods in all publications is provided. While most studies tried to focus on EEG AA correlates of depression, the samples were small and, in many cases, not representative. Using students as probands is common as is the use of nonclinical samples. A transfer of the evidence data to clinical patients is often not possible since no clinical samples were used for analysis. Most of the studies used only female participants. The classification of depressive status was measured using depression scores or symptom ratings according to ICD-10 and DSM-IV. Recording length varied between 2 and 8 minutes. The reference points for EEG measurement were placed on the ear, mastoid, nose, or the midline central position (Cz) in most of the studies. In detail, reference to common average (CA) was used in seven of 44 studies (15.9%), while nine of 44 (20.5%) studies used Cz as reference. Half of all studies (22/44) used the ear or the mastoid as reference, and four of 44 (9.1%) studies used the nose as reference.

Re-referencing was also common in some cases. Statistical analysis relied on correlational analysis and analyses of variance (ANOVAs) in most of the studies. Analysis of group differences and correlation was performed in 30.5% of studies, correlational analysis was performed only in 15.9% of studies, and group differences were performed in 52.3% of studies. The alpha band range was mostly fixed at 8--13 Hz (26/44 studies). Concerning the controlling for common known confounders ([Table 2](#t2-ndt-14-1493){ref-type="table"}), we found that 11 of 44 studies did not mention or even ignored the handedness of the participants. Only 15 studies relied on data of participants with tested handedness, while 18 studies relied on self-reported handedness. Regarding pharmacological treatment, only 15 of 44 (35%) studies reported this, and only 35% of the studies controlled for drugs in statistical analysis. Comorbidity was reported in 52% studies, and 30% studies controlled for it. Educational status was reported in 29.6% of all studies. Only nine of 44 (20.5%) studies included an additional task condition in the recording protocol. No study controlled for all common known confounders ([Table 2](#t2-ndt-14-1493){ref-type="table"}).

Discussion
==========

We conducted a systematic review on EEG AA in patients with DD, which is still discussed as a possible biomarker for depression.[@b1-ndt-14-1493]--[@b3-ndt-14-1493] However, the use of EEG AA as a surrogate marker for depression still remains unclear,[@b9-ndt-14-1493],[@b10-ndt-14-1493] which is not surprising if we take a closer look on the methodological quality of studies concerning EEG AA. The issues of small sample sizes and quality have been discussed repeatedly.[@b8-ndt-14-1493]--[@b10-ndt-14-1493] In our analysis, we found that many studies on EEG AA do not consider common known confounders, which could have a tremendous effect on the recorded EEG data.

Taking a closer look at meta-analyses,[@b9-ndt-14-1493],[@b10-ndt-14-1493] we found that most of the analyzed studies differ in sample age, education, gender, handedness, medication, clinical symptoms and severity, and comorbidity. EEG AA was tested as a biomarker for melancholia,[@b57-ndt-14-1493] with unclear validity.[@b8-ndt-14-1493],[@b10-ndt-14-1493],[@b20-ndt-14-1493],[@b58-ndt-14-1493] EEG AA seems to be the most robust in anxiety.[@b54-ndt-14-1493],[@b59-ndt-14-1493] In depression, a general decrease in EEG power can be found,[@b61-ndt-14-1493] which is a sign of cortical activity. This can also be found in rumination.[@b62-ndt-14-1493] Interventional studies have also been analyzed, which could prove a shift in EEG AA.[@b35-ndt-14-1493],[@b67-ndt-14-1493]--[@b69-ndt-14-1493]

Future studies on EEG AA need to focus on specific changes in the course of depression, which could also help answer the question if EEG AA is a state or trait marker for depression, which still remains unclear.[@b72-ndt-14-1493] If EEG AA is used as a diagnostic measure for clinical depression, we will need normative data. A simple lateralization measure of activity or idleness in the brain cannot be used across different genders, age, educational levels, left- and right-handedness, and medicated and not medicated individuals. In comparison to common correlational analysis and group comparison with ANOVAs, modern statistical analysis methods, such as peri-burst metrics, could help overcome the lack of temporal and spatial precision.[@b56-ndt-14-1493]

A consensus of proper sampling and controlling for confounders has to be found in order to validate or reject the hypothesis of EEG as a surrogate marker or marker for treatment response. The following section lists the minimal requirements for studies on EEG AA.

Guidelines for future studies on AA
-----------------------------------

Future studies on EEG AA ought to include the following commonly known confounders and recording protocols (controlling implies statistical consideration): clinical samples;controlling for handedness with a handedness inventory (eg, Edinburgh Handedness Inventory);controlling for drugs and point of taking;controlling for gender;controlling for age;controlling for cognition with cognitive test or screening;controlling for education;controlling for comorbidity with clinical screening; andEEG protocol including task and resting state condition.

Conclusion
==========

We conducted a literature search on EEG AA in DD and found that methodological flaws could account for the unclear results. Some of the studies do not take into consideration commonly known confounders such as education, age, gender, handedness, drugs, and comorbidity. We have designed a list of requirements to improve the quality of future studies on EEG AA, thus allowing a better comparison of results.
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Comparison of methods in studies on EEG AA

  No   Study                                    Sample                                                                                                                                              Age (years)                                            \% female                                                                                           Classification of depressive status        Method   EEG detail                                                                                                                     
  ---- ---------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------ --------------------------------------------------------------------------------------------------- ------------------------------------------ -------- -------------------------------------- ------------------------------------------ ------------------- --------- -------------- -------------------------------------------------------------------
  1    Liu et al[@b57-ndt-14-1493]              EG: N = 141 (38 melancholic MDD and 103 non-melancholic MDD)                                                                                        CG: 113 non-MDD patients                               EG1 -- melancholic: *M* = 35.92 (SD = 12.86) and EG2 -- non-melancholic: *M* = 32.79 (SD = 11.66)   CG: *M* = 32.56 (SD = 12.50)               66.50    SCID, HRS                              Group comparison                           LMas                EO + EC   6 × 1          7.8--12.7
  2    Cantisani et al[@b66-ndt-14-1493]        EG: 20 patients with a diagnosis of MDD                                                                                                             CG: 19 healthy adults                                  EG: *M* = 43.3 (SD = 14.03)                                                                         CG: *M* = 41.05 (SD = 13.82)               53.80    SCID, HAMD, MADRS, BDI                 Group comparison and correlation           CA                  EO + EC   6              8--12.5
  3    Arns et al[@b73-ndt-14-1493]             EG: 1,008 MDD patients                                                                                                                              CG: 336 healthy controls                               EG: *M* = 37.84 (SD = 12.6)                                                                         CG: *M* = 36.99 (SD = 13.1)                57       MINI-Plus, HRSD                        Group comparison                           LMas                EO + EC   2 × 2          8--13
  4    Stewart et al[@b71-ndt-14-1493]          EG: 143 MDD                                                                                                                                         CG: 163 healthy controls                               *M* = 19.1 (SD = 0.1)                                                                               Range: 17--34                              69.00    SCID, BDI                              Group comparison                           CA, Cz, LMas, CSD   EO + EC   8 × 1          8--13
  5    Manna et al[@b82-ndt-14-1493]            EG1: 14 high- anxiety depressive and EG2: 14 low-anxiety depressive                                                                                 CG: 21 healthy controls                                EG1: *M* = 39.9 (SD = 11.7) and EG2: *M* = 31.4 (SD = 11.7)                                         CG: *M* = 34.0 (SD = 11.8)                 57.10    BDI                                    Group comparison                           LMas                EO                       8--13
  6    Escolano et al[@b74-ndt-14-1493]         74 MDD patients were randomly allocated to the NF group (n = 50) or to the CG (n = 24)                                                              CG: 24 MDD patients randomly selected                  NF group: *M* = 53.70 (SD = 10.87)                                                                  CG: *M* = 49.50 (SD = 10.18)               68.30    BDI-II, PHQ-9                          Group comparison                           FPz, l ear          EO + EC   6              8--12
  7    Spronk et al, 2008[@b76-ndt-14-1493]     8 patients with MDD                                                                                                                                                                                        *M* = 42.6 (range 28--50)                                                                                                                      37.50    BDI, MINI-Plus                                                                    LMas                EO + EC   4              8--13; alpha 1 (8--11) and alpha 2 (11--13)
  8    Mathersul et al[@b54-ndt-14-1493]        428 subjects selected from the Brain Resource International Database                                                                                                                                       *M* = 34.85 (SD = 12.59), range 18--60                                                                                                         50       DASS-21                                Group comparison                           CA                  EC        2              8--13
  9    Pössel et al, 2008[@b77-ndt-14-1493]     80 mentally healthy adolescents                                                                                                                                                                            *M* = 13.92 (SD = 0.57), range: 13--15                                                                                                         43.75    DSQ, DISYPS-KJ: SBB-DE                 Regression analyses                        Nose                EO + EC   4 × 2          8--13
  10   Tops et al[@b79-ndt-14-1493]             11 healthy male volunteers                                                                                                                                                                                 *M* = 27.7, range: 19--42                                                                                                                      0        BDI                                    Group comparison                           l ear/LE            EO + EC   2              8--13
  11   Metzger et al[@b75-ndt-14-1493]          50 female Vietnam War nurse veterans                                                                                                                                                                       *M* = 53.7 (SD = 2.8)                                                                                                                          100      SCID, SCL-90-R                         Correlation                                LE                  EO + EC   2 × 3          8--13
  12   Kentgen et al[@b80-ndt-14-1493]          EG: 25 outpatients (19 MDD \[11 MDD + current anxiety disorder\] and 6 anxiety disorders)                                                           CG: 10 non-ill controls                                *M* = 15.5, range: 12.2--18.8                                                                                                                  100      PARIS, K-SADS, DISC-2.3-C              Group comparison                           Nose                EO + EC   2 × 3          7.8--12.5
  13   Graae et al[@b65-ndt-14-1493]            EG: 16 Hispanic females after suicide attempt                                                                                                       CG: 22 normal Hispanic adolescent girls                *M* = 14, range: 12--17                                                                                                                        100      BDI, HASS                              Group comparison                           Nose, C3 & C4       EO + EC   2 × 3          8--13
  14   Adolph and Margraf[@b59-ndt-14-1493]     43 healthy students showing symptoms of depression or anxiety                                                                                                                                              Range: 19--34                                                                                                                                  65.12    D-S                                    Regression analyses                        l-Mas               EO + EC   8              8--13
  15   Cantisani et al[@b66-ndt-14-1493]        EG: 20 MDD patients                                                                                                                                 CG: 19 healthy controls                                EG: *M* = 43.3 (SD = 14.03)                                                                         CG: *M* = 41.05 (SD = 13.82)               53.80    SCID, HAMD, MADRS, BDI                 Group comparison and correlation           Cz                  EC        6              Lower alpha: 8--10 and upper alpha: 10.5--12.5
  16   Moynihan et al[@b67-ndt-14-1493]         EG: 105 MBSR group                                                                                                                                  CG: 103                                                EG: *M* = 73.3 (SD = 6.7)                                                                           CG: *M* = 73.6 (SD = 6.7)                  59.60    CES-D-R                                Group comparison                           r-Mas               EO + EC   8 × 1          8--13
  17   Bruder et al[@b81-ndt-14-1493]           EG: high-risk group (37)                                                                                                                            CG: low-risk group (38)                                EG: *M* = 33.9 (SD = 11.7)                                                                          CG: *M* = 27.4 (SD = 13.5)                 53.33    SADS-L, K-SADS-E, K-SADS-PL            Group comparison and correlation           l ear               EO + EC   4 × 2          7.0--12.5
  18   Keune et al[@b68-ndt-14-1493]            N = 57 recurrently depressed women in remission EG: mindfulness support group 25                                                                    CG: rumination challenge group (32)                    EG: *M* = 43.56 (SD = 9.67)                                                                         CG: *M* = 49.09 (SD = 10.82)               100      BDI-II, PANAS                          Group comparison and correlation           LMas                EO + EC   8 × 1 and 10   8--13
  19   Segrave et al[@b85-ndt-14-1493]          EG: 16 MDD                                                                                                                                          CG: 18 controls                                        EG: *M* = 40.75 (SD = 11.39)                                                                        CG: *M* = 42.11 (SD = 13.02)               100      BDI, MINI-Plus, MADRS                  Group comparison                           Cz, CA              EO + EC   2 × 3          8--13 and IAF
  20   Chan et al[@b55-ndt-14-1493]             Participants with depression, EG1: 17 CBT and EG2: 17 DMBI                                                                                          Participants with depression, CG: WL                   EG1: *M* = 46.94 (SD = 6.54) and EG2: *M* = 47.06 (SD = 9.54)                                       CG: *M* = 45.44 (SD = 8.25)                80       SCID                                   Group comparison and correlation           LE                  EC        5              8--13
  21   Gordon et al[@b60-ndt-14-1493]           EG: 567 participants across 6 clinical groups                                                                                                       CG: 1,908 healthy control participants from the BRID   Range: 6--87                                                                                                                                   45.80    MINI                                   Group comparison                           LMas                EO + EC   2 × 2          8--13
  22   Kemp et al[@b51-ndt-14-1493]             EG: 14 patients with PTSD and 15 patients with MDD                                                                                                  CG: 15 healthy controls                                EG -- PTSD: *M* = 41.4 (SD = 12.3) and MDD: *M* = 39.9 (SD = 14.0)                                  CG: *M* = 42.4 (SD = 16.7)                 61.40    MINI, HRSD, DASS                       Group comparison                           LMas                EC        2              8--13
  23   Beaton et al[@b63-ndt-14-1493]           Undergraduate students, EG: 24 high socially anxious                                                                                                Undergraduate students, CG: 25 low socially anxious    *M* = 20.32 (SD = 4.18)                                                                                                                        75.50    DASS-21                                Group comparison and correlation           Cz                  EC + EO   2              8--13
  24   De Raedt et al[@b64-ndt-14-1493]         20 volunteer students                                                                                                                                                                                                                                                                                                                                     85       BDI-II                                 Regression analyses                        Cz                  EC        2              8--12
  25   Bruder et al[@b84-ndt-14-1493]           EG1: 19 highest risk group and EG2: 14 intermediate risk group                                                                                      CG: 16 lowest risk group                               EG1: *M* = 15.4 (SD = 4.7) and EG2: *M* = 10.6 (SD = 4.5)                                           CG: *M* = 13.6 (SD = 6.2)                  53       SADS-L, K-SADS-E, K-SADS-PL            Group comparison                           LE                  EO + EC   4 × 2          7.0--12.5
  26   McFarland et al[@b70-ndt-14-1493]        70 participants                                                                                                                                                                                            *M* = 34.64 (SD = 12.97), range: 18--63                                                                                                        65.70    SCID                                   Correlation                                LE                  EO + EC   6 × 1          8--13
  27   Diego et al[@b52-ndt-14-1493]            Woman (effects of maternal depression), EG: 20 undefined (CES-D = 0--2); 10 borderline (CES-D = 13--15), 69 depressed (CES-D \>16)                  CG: 64 non- depressed (CES-D = 3--12)                  *M* = 23 (SD = 5.0)                                                                                                                            100      CES-D                                  Group comparison and correlation           Cz                            3              8--12
  28   Bruder et al[@b4-ndt-14-1493]            EG: 44 depressed outpatients                                                                                                                        CG: 26 normal patients                                 EG: anxious group: *M* = 36.7 (SD = 11.5); Nonanxious: *M* = 41.3 (SD = 10.7)                       CG: *M* = 32.9 (SD = 9.8)                  50       BDI                                    Group comparison and correlation           Nose                EO + EC   2 × 3          7.8--12.5
  29   Tomarken et al[@b53-ndt-14-1493]         EG: 25 high-risk patients                                                                                                                           CG: 13 low-risk patients                               EG: *M* = 13.1 (SD = 0.3)                                                                           CG: *M* = 13.0 (SD = 0.4)                  52.60    SCID, K-SADS-E, CDI, K-LIFE            Group comparison and regression analyses   Cz                  EO + EC   8 × 1          8.5--12.5
  30   Jesulola et al[@b20-ndt-14-1493]         100 participants                                                                                                                                                                                           32.5 (SD = 14.13)                                                                                                                              54       SDS                                    Group comparison and correlation           CA                  EO + EC   3 × 3          8--13
  31   Kaiser et al[@b17-ndt-14-1493]           39 females: EG1: anxiety + depression; EG2: depression participants                                                                                 CG: healthy participants                               EG1: *M* = 78.6 (SD = 6.7) and EG2: *M* = 80.5 (SD = 5.7)                                           CG: *M* = 80.9 (SD = 7.0)                  100      HADS-A, HADS-D, GDS                    Group comparison and correlation           r-Mas               EC + EO   3              Alpha 1 (6.9--8.9), alpha 2 (8.9--10.9), and alpha 3 (10.9--12.9)
  32   Brzezicka et al[@b83-ndt-14-1493]        EG: 26 depressed patients                                                                                                                           CG: 26 controls                                        *M* = 26.42 (SD = 6.5)                                                                                                                                  ICD-10 classification criteria         Group comparison and correlation           CSD                 EC        5              8--13
  33   Mennella et al[@b35-ndt-14-1493]         EG: 23 dysphoric individuals                                                                                                                        CG: 24 nondysphoric individuals                        EG: *M* = 21.0 (SD = 1.6)                                                                           CG: *M* = 15.9 (SD = 4.4)                  100      BDI-II, SCID                           Group comparison                           l-Mas               EO        5              8--13
  34   Quinn et al[@b58-ndt-14-1493]            EG: 117 MDD patients (57 with melancholia and 60 with non- melancholia)                                                                             CG: 120 healthy controls                                                                                                                                                                                       MINI-Plus                              Group comparison                           LMas, CA            EC        2              8--13
  35   Gold et al[@b8-ndt-14-1493]              79 adults                                                                                                                                                                                                  *M* = 35.6 (SD = 9.8), range: 18--50                                                                                                           78.5     MADRS, HADS-A                          Correlations                               EC                  EC        5              8--12
  36   Allen and Cohen[@b56-ndt-14-1493]        306 young adults -- 143 with MDD                                                                                                                                                                           *M* = 19.1 (SE = 0.1), range: 17--34                                                                                                           69       BDI                                    Group comparison and correlation           Cz, CSD             EC + EO   8              8--13
  37   Saletu et al[@b61-ndt-14-1493]           EG: 60 female depressed menopausal syndrome patients                                                                                                CG: 30 normal controls                                 EG: *M* = 51.10 (SD = 3.13)                                                                                                                    100      DSM-IIIR                               Group comparison (SPM)                                         EC        7              8--10
  38   Carvalho et al[@b16-ndt-14-1493]         EG1: 12 depressed patients and EG2: 8 remitted patients                                                                                             CG: 7 non-depressed patients                           *M* = 71.3                                                                                                                                     66.60    DSM-IV                                 Group comparison                           l ear               EC        8              8--12.9
  39   Deslandes et al[@b15-ndt-14-1493]        EG: 22 depressed elderly participants                                                                                                               CG: 14 healthy elderly participants                    EG: *M* = 71.6 (SD = 1.2)                                                                           CG: *M* = 72.4 (SD = 1.7)                  94.40    DSM-IV                                 Group comparison                           LE                  EC        8              8--13
  40   Putnam and McSweeney[@b62-ndt-14-1493]   EG: 6 depressed outpatient groups                                                                                                                   CG: 7 healthy CG                                       EG: *M* = 32.6 (SD = 12.1)                                                                          CG: *M* = 32.8 (SD = 11.3)                 69.20    BDI                                    Group comparison                           Cz                  EC + EO   4 × 4          8--13
  41   Barnhofer et al[@b69-ndt-14-1493]        22 individuals with a previous history of suicidal depression were randomly assigned to either MBCT (n = 10) or treatment-as-usual group (n = 12)   CG: 12 treatment-as-usual group                        EG: *M* = 48.0 (SD = 10.2)                                                                          CG: *M* = 38.6 (SD = 9.6)                  50       BDI                                    Group comparison                           CA, LE              EC + EO   8              8--13
  42   Bruder et al[@b47-ndt-14-1493]           EG1: 18 subjects were both parents and had an MDD and EG2: 40 subjects were one parent and had an MDD                                               CG: 29 subjects were neither parent and had an MDD     EG1: *M* = 29.0 (SD = 11.0), range: 8--47 and EG2: *M* = 37.0 (SD = 8.0), range: 22--50             CG: *M* = 37.1 (SD = 4.7), range: 29--47   60.90    SADS-L, K-SADS-E, K-SADS-PL            Group comparison                           l ear               EC        4 × 2          7.0--12.5
  43   Allen et al[@b14-ndt-14-1493]            30 women                                                                                                                                                                                                   range: 18--45                                                                                                                                  100      SCID                                   Group comparison and correlation           Cz, LMas            EO + EC   8              8--13
  44   Debener et al[@b72-ndt-14-1493]          EG: 15 clinically depressed patients                                                                                                                CG: 22 healthy adults                                  EG: *M* = 48.5, range: 23--64                                                                       CG: *M* = 45.9, range: 26--64              67.6     Structural clinical interview ICD-10   Group comparison                           LE                  EO + EC   2              8--13

**Abbreviations:** AA, alpha asymmetry; BDI, Beck Depression Inventory; BRID, Brain Resource International Database; C3 and C4, average between central left and right; CA, common average; CBT, cognitive behavioral therapy; CG, control group; CES-D-R, depression scale-revised; CSD, current source density transformation; Cz, the midline central position; DASS, depression anxiety stress scales; DISC-2.3-C, Diagnostic Interview Schedule for Children; DISYPS-KJ: SBB-DE, self-rating questionnaire for depressive disorders measures symptom criteria in accordance with DSM-IV diagnoses of depressive disorders; DSQ, depressions-screening questionnaire; DMBI, Chan-based Dejian mind-body intervention; DSM-IIIR, *Diagnostic and Statistical Manual of Mental Disorders*, Third Edition, Revised; DSM-IV, *Diagnostic and Statistical Manual of Mental Disorders*, Fourth Edition; EC, eyes closed; EEG, electroencephalogram; EG, experimental group; EO, eyes open; FPz, frontal-midline electrode; GDS, geriatric depression scale; HADS-A, hospital anxiety and depression scale; HADS-D, hospital anxiety and depression scale -- German version; HAMD, Hamilton depression rating scale; HASS, Harkavy, Asnis Suicide scale; HRS, Hamilton rating scale; HRSD, Hamilton rating scale for depression; K-SADS, schedule for affective disorders and schizophrenia; K-SADS-PL, Kiddie-sads-present and lifetime version; LE, left ear; LMas, left-mastoid; *M*, median; MADRS, Montgomery--Åsberg Depression Rating Scale; MBCT, Mindfulness-based cognitive therapy; MBSR, mindfulness-based stress reduction; MINI-Plus, mini-international neuropsychiatric interview; MDD, major depressive disorder; NF, neurofeedback; PANAS, positive and negative affect scales; PARIS, Parent as Respondent Informant Schedule; PHQ-9, Patient Health Questionnaire; PTSD, posttraumatic stress disorder; SE, standard error; SADS-L, schedule for affective disorders and schizophrenia lifetime version for adults and for children between the ages 6 and 17, the child version (K-SADS-E); SCID, structured clinical interview for DSM-IV; SCL-90-R, symptom checklist revised; SPM, statistical parametric maps; WL, waitlist control group.

###### 

Controlling for common known confounders

  Study                                    Controlled for                       
  ---------------------------------------- ---------------- --- --- --- --- --- ---
  Debener et al[@b72-ndt-14-1493]          x                    x   x           x
  Manna et al[@b82-ndt-14-1493]            x                    x           x   
  Carvalho et al[@b16-ndt-14-1493]         x                        x       x   
  Segrave et al[@b85-ndt-14-1493]          x                        x           x
  Deslandes et al[@b15-ndt-14-1493]        x                        x           x
  Allen and Cohen[@b56-ndt-14-1493]        x                            x       x
  Allen et al[@b14-ndt-14-1493]            x                            x       x
  Tomarken et al[@b53-ndt-14-1493]         x                            x       
  Graae et al[@b65-ndt-14-1493]            x                                x   
  Stewart et al[@b71-ndt-14-1493]          x                                    x
  Cantisani et al[@b66-ndt-14-1493]        x                    x   x       x   
  Cantisani et al[@b66-ndt-14-1493]        x                    x   x       x   
  Bruder et al[@b4-ndt-14-1493]            x                    x       x   x   
  Kemp et al[@b51-ndt-14-1493]             x                        x       x   
  Pössel et al[@b77-ndt-14-1493]           x                                x   
  Kaiser et al[@b17-ndt-14-1493]                            x   x   x           
  Putnam and McSweeney[@b62-ndt-14-1493]                    x   x       x       x
  McFarland et al[@b70-ndt-14-1493]                         x   x           x   
  Bruder et al[@b84-ndt-14-1493]                            x       x       x   
  Barnhofer et al[@b69-ndt-14-1493]                         x       x           x
  Kentgen et al[@b80-ndt-14-1493]                           x           x   x   
  Menella et al[@b78-ndt-14-1493]                           x           x   x   
  Quinn et al[@b58-ndt-14-1493]                             x           x   x   
  Adolph and Margraf[@b59-ndt-14-1493]                      x           x       x
  Beaton et al[@b63-ndt-14-1493]                            x           x       x
  Liu et al[@b57-ndt-14-1493]                               x               x   
  Keune et al[@b68-ndt-14-1493]                             x               x   
  Gold et al[@b8-ndt-14-1493]                               x               x   
  Bruder et al[@b47-ndt-14-1493]                            x               x   
  Tops et al[@b76-ndt-14-1493]                              x                   x
  Brzezicka et al[@b83-ndt-14-1493]                         x                   
  Metzger et al[@b75-ndt-14-1493]                           x   x       x   x   
  Mathersul et al[@b54-ndt-14-1493]                         x           x       x
  Moynihan et al[@b67-ndt-14-1493]                              x   x       x   
  Chan et al[@b55-ndt-14-1493]                                  x   x       x   
  Arns et al[@b73-ndt-14-1493]                                  x       x   x   
  Diego et al[@b52-ndt-14-1493]                                 x       x       
  Bruder et al[@b81-ndt-14-1493]                                    x       x   
  Spronk et al[@b76-ndt-14-1493]                                    x           
  Saletu et al[@b61-ndt-14-1493]                                    x           
  Gordon et al[@b60-ndt-14-1493]                                        x       x
  Escolano et al[@b74-ndt-14-1493]                                          x   
  De Raedt et al[@b64-ndt-14-1493]                                              
  Jesulola et al[@b20-ndt-14-1493]                                              

**Note:** x indicates variable was controlled.
